Christopher Ott, Ph.D. - The Pablove Foundation

Christopher Ott, Ph.D.

Massachusetts General Hospital

Discovery of Epigenetic Factors Essential for T Cell Leukemia

Read About Dr. Ott's Findings

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300.

Dr. Ott is a bright junior investigator at Massachusetts General Hospital. The aim of his Powered by Pablove seed grant project is to identify proteins critical for the survival of T-cell Leukemia cells as well as new drug agents that can be effective in treating this difficult disease.

Awarded in 2018